Skip to main content
SpringerLink
Log in

Primary Angioplasty in Community Hospitals without On-Site Cardiac Surgery

  • Chapter
Primary Angioplasty in Acute Myocardial Infarction

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 70 Accesses

Abstract

It is now firmly established that primary angioplasty is superior to fibrinolytic therapy for the treatment of acute myocardial infarction (AMI) in lytic-eligible patients (1–3) when the procedure is performed at qualified centers. Compared with fibrinolytic therapy, primary angioplasty has been demonstrated to reduce rates of death, stroke, recurrent ischemia, and reinfarction (1). In the current era of newer generation stents and glycoprotein (GP) IIb/IIIa platelet inhibitors, the advantage of primary angioplasty over fibrinolytic therapy is even more clear. One recent randomized trial of 140 patients showed that the combined incidence of death, reinfarction, and stroke at 6 mo was almost three times greater in patients treated with fibrinolytics than with coronary stenting and abciximab (8.5% vs 23.2%, p = 0.02; relative risk, 0.34; 95% confidence interval, 0.13– 0.88)(2). Recently pooled “real world” outcomes of 9906 patients with AMI in two current German registries demonstrated that primary angioplasty was independently associated with lower hospital mortality compared with fibrinolytic therapy in all subgroups, whether high or low risk: 6.4% vs 11.3%, respectively (odds ratio [OR] 0.54, 95% confidence interval [C I] 0.43–0.67) (3). Other reports indicate that patients with low-risk AMI treated with primary angioplasty have very low rates of in-hospital mortality (1%) (4,5), fewer reinfarctions, and decreased hospital costs as a result of safe early discharge (3–4 d) and avoidance of both intensive care and in-hospital exercise testing (4). The benefits of primary angioplasty over fibrinolytic therapy have been shown to be sustained over 5 yr (6). Moreover, early knowledge of the coronary anatomy gained from the initial angiogram enables greater diagnostic precision and more informed therapeutic decisions and enhances risk stratification (4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weaver WD, Simes J, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous fibrinolytic therapy for acute myocardial infarction. JAMA 1997; 278: 2093–2098.

    Article  PubMed  CAS  Google Scholar 

  2. Schömig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/ IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000; 343: 385–391.

    Article  PubMed  Google Scholar 

  3. Zahn R, Schiele R, Schneider S, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy In Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J Am Coll Cardiol 2001; 37: 1827–1835.

    Article  PubMed  CAS  Google Scholar 

  4. Grines CL, Marsalese DL, Brodie B, et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. J Am Coll Cardiol 1998; 31: 967–972.

    Article  PubMed  CAS  Google Scholar 

  5. Zijlstra F, Beukema WP, van’t Hof AW, et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1997; 29: 908–912.

    Article  PubMed  CAS  Google Scholar 

  6. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341: 1413–1419.

    Article  PubMed  CAS  Google Scholar 

  7. Barron HV, Bowlby LJ, Breen T, et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation 1998; 97: 1150–1156

    Article  PubMed  CAS  Google Scholar 

  8. Grines CL, Booth DC, Nissen SE, et al. Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications. Am J Cardiol 1990; 65: 1292–1296.

    Article  PubMed  CAS  Google Scholar 

  9. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615–1622.

    Article  Google Scholar 

  10. Zahn R, Schuster S, Schielel R, et al. Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Catheter Cardiovasc Interv 1999; 46: 127–133.

    Article  PubMed  CAS  Google Scholar 

  11. Zahn R, Schiele R, Schneider S, et al. Primary dilatation versus thrombolysis in patients with acute myocardial infarct, not included in randomized studies. Results of the MITRA Study: Maximal Individual Optimized Therapy for Acute Myocardial Infarct. Z Kardiol 1999; 88: 418–425.

    Article  PubMed  CAS  Google Scholar 

  12. Scull GS, Martin JS, Weaver WD, Every NR, for the MITI Investigators. Early angiography versus conservative treatment in patients with non-ST elevation acute myocardial infarction. J Am Coll Cardiol 2000; 35: 895–902.

    Article  PubMed  CAS  Google Scholar 

  13. Thiemann DR, Coresh J, Schulman SP, et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2000; 101: 2239–2246.

    Article  PubMed  CAS  Google Scholar 

  14. Ayanian JZ, Braunwald E. Thrombolytic therapy for patients with myocardial infarction who are older than 75 years. Circulation 2000; 101: 2224–2226.

    Article  PubMed  CAS  Google Scholar 

  15. Berger AK, Schulman KA, Gersh BJ, et al. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA 1999; 282: 341–348.

    Article  PubMed  CAS  Google Scholar 

  16. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994; 90: 2103–2114.

    Article  PubMed  CAS  Google Scholar 

  17. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311–322.

    Google Scholar 

  18. The TIMI Study Group. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994; 89: 1545–1556.

    Article  Google Scholar 

  19. The TIMI study group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985; 312: 932–936.

    Google Scholar 

  20. Garcia E, Elizaga J, Perez-Castellano N, et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol 1999; 33: 605–611.

    Article  PubMed  CAS  Google Scholar 

  21. Foot DK, Lewis RP, Pearson TA, Beller GA. Demographics and cardiology, 1950–2050. J Am Coll Cardiol 2000; 35: 66B–80B.

    PubMed  CAS  Google Scholar 

  22. Every NR, Maynard C, Schulman K, Ritchie JL. The association between institutional primary angioplasty procedure volume and outcome in elderly Americans. J Invas Cardiol 2000; 12: 303–308.

    CAS  Google Scholar 

  23. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patient undergoing angioplasty for acute myocardial infarction. JAMA 2000; 283: 2941–2947.

    Article  PubMed  CAS  Google Scholar 

  24. Canto JG, Every NR, Magid DJ, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. N Engl J Med 2000; 342: 1573–1580.

    Article  PubMed  CAS  Google Scholar 

  25. Joint Working Group on Coronary Angioplasty of the British Cardiac Society and British Cardiovascular Intervention Society. Coronary angioplasty: guidelines for good practice and training. Heart 2000; 83: 224–235.

    Article  Google Scholar 

  26. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999; 341: 625–634.

    Article  PubMed  CAS  Google Scholar 

  27. Holmes DR Jr, Topol EJ, Berger PB, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 1995; 26: 668–674.

    Article  PubMed  Google Scholar 

  28. Antoniucci D, Valenti R, Santoro GM, et al. Systematic direct angioplasty and stentsupported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998; 31: 294–300.

    Article  PubMed  CAS  Google Scholar 

  29. Bengtson J, Kaplan J, Pieper K, et al. Prognosis in cardiogenic shock after myocardial infarction in the interventional era. J Am Coll Cardiol 1992; 20: 1482–1488.

    Article  PubMed  CAS  Google Scholar 

  30. Stomel RJ, Basak M, Bates ER. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 1994; 105: 997–1002.

    Article  PubMed  CAS  Google Scholar 

  31. Kovack PJ, Stomel RJ, Ohman EM, et al. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 1997; 29: 1454–1458.

    Article  PubMed  CAS  Google Scholar 

  32. Berger PB, Topol EJ, Califf RM, et al. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. Circulation 1997; 96: 122–127.

    Article  PubMed  CAS  Google Scholar 

  33. Hernandez F, Hernandez P, Tascon JC, et al. Emergency revascularization and hybrid approaches in cardiogenic shock. Eur Heart J 1999; 20 (Suppl): 169 (abstract).

    Google Scholar 

  34. Wharton TP Jr, McNamara NS, Lew D, et al. Cardiogenic shock at community hospitals with no surgery on site: outcomes after primary angioplasty in 101 patients in a multicenter registry. Circulation 1998;98(Suppl I):I-307–8 (abstract).

    Google Scholar 

  35. Wharton TP Jr, McNamara NS, Fedele FA, et al. Primary angioplasty for the treatment of acute myocardial infarction: experience at two community hospitals without cardiac surgery. J Am Coll Cardiol 1999; 33: 1257–1265.

    Article  PubMed  Google Scholar 

  36. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999; 34: 890–911.

    Article  PubMed  CAS  Google Scholar 

  37. Rogers WJ, Canto JG, Barron HV, et al. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction. J Am Coll Cardiol 2000; 35: 371–379.

    Article  PubMed  CAS  Google Scholar 

  38. Mehta RH, Stalhandske EJ, McCargar PA, et al. Elderly patients at highest risk with acute myocardial infarction are more frequently transferred from community hospitals to tertiary centers: reality or myth? Am Heart J 1999; 138: 688–695.

    Article  PubMed  CAS  Google Scholar 

  39. The Society for Cardiac Angiography and Interventions. Directory of cardiac catheterization laboratories in the United States, 4th edit. Raleigh, NC; 1996.

    Google Scholar 

  40. Vogel J. Angioplasty in the patient with an evolving myocardial infarction: with and without surgical backup. Clin Cardiol 1992; 15: 880–882.

    Article  PubMed  CAS  Google Scholar 

  41. Weaver WD, Litwin PE, Martin JS. Use of direct angioplasty for treatment of patients with acute myocardial infarction in hospitals with and without on-site cardiac surgery. Circulation 1993; 88: 2067–2075.

    Article  PubMed  CAS  Google Scholar 

  42. Iannone LA, Anderson SM, Phillips SJ. Coronary angioplasty for acute myocardial infarction in a hospital without cardiac surgery. Texas Heart Inst J 1993; 20: 99–104.

    CAS  Google Scholar 

  43. Ayres M. Coronary angioplasty for acute myocardial infarction in hospitals without cardiac surgery. J Invas Cardiol 1995; 7 (SupplF): 40F–48F.

    Google Scholar 

  44. Weaver WD, Parsons L, Every N. Primary coronary angioplasty in hospitals with and without surgery backup. J Invas Cardiol 1995; 7 (SupplF): 34F–39F.

    Google Scholar 

  45. Brush JE, Thompson S, Ciuffo AA, et al. Retrospective comparison of a strategy of primary coronary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction in a community hospital without cardiac surgery. J Invas Cardiol 1996; 8: 91–98.

    Google Scholar 

  46. Weaver WD for the MITI Project Investigators. PTCA in centers without surgical backup— outcome, logistics, and technical aspects. J Invas Cardiol 1997; 9 (SupplB): 20B–23B.

    Google Scholar 

  47. Smyth DW, Richards AM, Elliott JM. Direct angioplasty for myocardial infarction: one-year experience in a center with surgical backup 220 miles away. J Invas Cardiol 1997; 9: 324–332.

    Google Scholar 

  48. Wharton TP Jr, Johnston JD, Turco MA, et al. Primary angioplasty for acute myocardial infarction with no surgery on site: outcomes, core angiographic analysis, and six-month follow-up in the 500-patient prospective PAMI—No S.O.S. Registry. J Am Coll Cardiol 1999; 33: 352A–353A (abstract).

    Google Scholar 

  49. Ribichini F. Experiences with primary angioplasty without on site-cardiac surgery. Semin Intervent Cardiol 1999; 4: 47–53.

    CAS  Google Scholar 

  50. Ribichini F, Steffenino G, Dellavalle A, et al. Primary angioplasty without surgical back-up at all. Results of a five years experience in a community hospital in Europe. J Am Coll Cardiol 2000; 35: 364A (abstract).

    Google Scholar 

  51. Aversano T, et al. Atlantic cardiovascular patient outcomes research team trial of primary percutaneous coronary intervention vs thrombolysis in acute MI (C-PORT PCI). Oral presentation during the 73rd Annual Scientific Sessions of the American Heart Association, 2000 Nov 12–15; New Orleans, LA. Available from URL: http://www.scientificsessions.org/ archive/abstract/clinicaltrialsresults @ CPORT-PCI.pdf

    Google Scholar 

  52. Stone GW, Brodie BR, Griffin JJ, et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 1998; 31: 23–30.

    Article  PubMed  CAS  Google Scholar 

  53. Antoniucci D, Santoro GM, Bolognese L, et al. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. Results of the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. J Am Coll Cardiol 1998; 31: 1234–1239.

    Article  PubMed  CAS  Google Scholar 

  54. Suryapranata H, van’t Hof AW, Hoorntje JCA, et al. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502–2505.

    Article  PubMed  CAS  Google Scholar 

  55. Brener SJ, Barr LA, Burchenal J, et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. The RAPPORT trial. Circulation 1998; 98: 734–741.

    Article  PubMed  CAS  Google Scholar 

  56. Topol EJ, Mark DB, Lincoff AM, et al. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1999; 354: 2019–2024.

    Article  PubMed  CAS  Google Scholar 

  57. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999; 341: 1949–1956.

    Article  PubMed  CAS  Google Scholar 

  58. Katz S, Green SJ, Kaplan BM, et al. Nonrandomized comparison between stent deployment and percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am Heart J 2000; 139: 44–51.

    Article  PubMed  CAS  Google Scholar 

  59. Kleiman NS, Lincoff AM, Flaker GC, et al. Early percutaneous coronary intervention, platelet inhibition, and clinical outcomes in patients with acute coronary syndromes. Circulation 2000; 101: 751–757.

    Article  PubMed  CAS  Google Scholar 

  60. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: 1328–1419.

    Article  Google Scholar 

  61. Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001; 37: 2215–2238.

    Article  PubMed  Google Scholar 

  62. Expert Panel on Invasive Cardiology in Ontario, Cardiac Care Network of Ontario: final report and recommendations. Submitted to the Ontario Ministry of Healthy and Long-Term Care, June 2001. Available from URL: http://www.ccn.on.ca.

    Google Scholar 

  63. Loubeyre C, Morice MC, Berzin B, et al. Emergency coronary artery bypass surgery following coronary angioplasty and stenting: results of a French multicenter registry. Cathet Cardiovasc Intervent 1999; 48: 441–448.

    Article  Google Scholar 

  64. Stone GW, Brodie B, Griffin J, et al. Role of cardiac surgery in the hospital phase management of patients treated with primary angioplasty for acute myocardial infarction. Am J Cardiol 2000; 85: 1292–1296.

    Article  PubMed  CAS  Google Scholar 

  65. Shubrooks SJ Jr, Nesto RW, Leeman D, et al. Urgent coronary bypass surgery for failed percutaneous coronary intervention in the stent era: is backup still necessary? Am Heart J 2001; 142: 190–196.

    Article  PubMed  Google Scholar 

  66. Haraphongse M, Kunjara Na-Ayudhaya R, Burton J, et al. Clinical efficacy of emergency bypass surgery for failed coronary angioplasty. Can J Cardiol 1990; 6: 186–190.

    PubMed  CAS  Google Scholar 

  67. Richardson SG, Morton P, Murtagh JG, et al. Management of acute coronary occlusion during percutaneous transluminal coronary angioplasty: experience of complications in a hospital without on site facilities for cardiac surgery. Br Med J 1990; 300: 355–358.

    Article  CAS  Google Scholar 

  68. Carey JA, Davies SW, Balcon R, et al. Emergency surgical revascularization for coronary angioplasty complications. Br Heart J 1994; 72: 428–435.

    Article  PubMed  CAS  Google Scholar 

  69. Simpson DE, Boura JA, Grines LL, Grines CL. Predictors of delay from ER to cath with primary PTCA for acute MI. J Am Coll Cardiol 2000; 35: 3520A (abstract).

    Google Scholar 

  70. Widimsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000; 10: 823–831.

    Article  Google Scholar 

  71. Tiefenbrunn AJ, Chandra NC, Every NR, et al. High mortality in patients with myocardial infarction transferred for primary angioplasty: a report from the National Registry of Myocardial Infarction-2. Circulation 1997; 96 (Suppl I): I–531 (abstract).

    Google Scholar 

  72. Grines CL, Balestrini C, Westerhausen DR Jr, et al. A randomized trial of thrombolysis vs transfer for primary PTCA in high risk AMI patients: results of the AIR PAMI trial. J Am Coll Cardiol 2000; 35: 376A (abstract).

    Google Scholar 

  73. Wharton TP Jr, McNamara NS. Management of acute coronary syndromes in the community hospital without cardiac surgery: how can access to interventional therapy be improved? Am J Cardiovasc Drugs 2001; 1: 375–385.

    Article  PubMed  Google Scholar 

  74. Ernst N, de Boer MJ, van’t Hof AW, et al. Prehospital infarction angioplasty triage (PHIAT): results from the Zwolle myocardial infarction study group. J Am Coll Cardiol 2001; 37: 339A (abstract).

    Google Scholar 

  75. Reifart W, Schwarz F, Preusler W, Stoerger H, Hofmann M. Results of PTCA in more than 5,000 patients without surgical standby in the same center. J Am Coll Cardiol 1992; 19: 229A (abstract).

    Google Scholar 

  76. Meier B, Urban P, Dorsaz PA, Favre J. Surgical standby for coronary balloon angioplasty. JAMA 1992; 268: 741–745.

    Article  PubMed  CAS  Google Scholar 

  77. Klinke WP, Hui W. Percutaneous transluminal coronary angioplasty without on-site surgical facilities. Am J Cardiol 1992; 770: 1520–1525.

    Article  Google Scholar 

  78. Ribichini F, Uslenghi E, Picco L, et al. Elective coronary angioplasty in total absence of heart surgery. G Ital Cardiol 1994; 24: 949–956.

    PubMed  CAS  Google Scholar 

  79. Reifart N, Preusler W, Schwarz F, et al. A large center experience of coronary angioplasty without on-site surgical standby. In: Topol EJ, Serruys PW, eds. Current Review of Interventional Cardiology, 2nd edit. Current Medicine, Philadelphia; 1995, pp. 296–303.

    Google Scholar 

  80. Dellavalle A, Steffenino G, Ribichini F, et al. Elective coronary angioplasty with and without surgical standby: clinical and angiography for the selection of patients. Coron Arter Dis 1995; 6: 513–520.

    CAS  Google Scholar 

  81. Shaw TRD, Starkey IR, Essop AR, et al. Emergency coronary bypass surgery after vessel occlusion at angioplasty in centres without on-site facilities for cardiac surgery. Br Heart J 1989; 61: 438 (abstract).

    Google Scholar 

  82. Baduini G, Belli KR, de Benedicdtis M, et al. Coronary angioplasty in an Italian hospital without on-site cardiac surgery: the results and outlook [in Italian]. G Ital Cardiol 1994; 24: 1529–1536.

    PubMed  CAS  Google Scholar 

  83. Vogt A, Bonzel T, Harmjanz D. PTCA registry of German community hospitals. Eur Heart J 1997; 18: 1110–1114.

    Article  PubMed  CAS  Google Scholar 

  84. McNamara NS, Hiett D, Allen B, et al. Can community hospitals provide effective primary PTCA coverage at all hours? J Am Coll Cardiol 1997; 29: 91A (abstract).

    Google Scholar 

  85. O’Neill WW, Brodie BR, Ivanhoe R, et al. Primary coronary angioplasty for acute myocardial infarction (The Primary Angioplasty Registry). Am J Cardiol 1994;73:627– 634.

    Google Scholar 

  86. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673–679.

    Article  PubMed  CAS  Google Scholar 

  87. Zijlstra F, Jan de Beer M, Hoorntje JCA, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680–684.

    Article  PubMed  CAS  Google Scholar 

  88. McNamara NS, Wharton TP Jr, Johnston J, et al. Can hospitals with no surgery on site provide effective infarct intervention at all hours? The PAMI-No SOS experience. Circulation 1998;98(Suppl I):I-306-I-307 (abstract).

    Google Scholar 

  89. Johnston J, O’Neill W, Slota P, et al. Primary PTCA at community hospitals without surgical backup is performed as effectively and with less delay compared to tertiary care centers. Circulation 1998; 98 (Suppl I): I - 770 (abstract).

    Google Scholar 

  90. Tiefenbrunn AJ, Chandra NC, French WJ, et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 1998;31:1240– 1245.

    Google Scholar 

  91. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996; 335: 1253–1260.

    Article  PubMed  CAS  Google Scholar 

  92. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Circulation 2000; 101: 2788–2794.

    Article  Google Scholar 

  93. Antman EM, Giugliano RP, Gibson M, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial. Circulation 1999; 99: 2720–2732.

    Article  PubMed  CAS  Google Scholar 

  94. Murakami T, Mizuno S, Takahashi Y. Intracoronary aspiration thrombectomy for acute myocardial infarction. Am J Cardiol 1998; 82: 839–844.

    Article  PubMed  CAS  Google Scholar 

  95. O’Neill WW. Coronary thrombosis during acute myocardial infarction. Roberts was right ! Am J Cardiol 1998; 82: 896–897.

    Article  PubMed  Google Scholar 

  96. Brodie BR, Stuckey TD, Wall TC, et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998; 32: 1312–1319.

    Article  PubMed  CAS  Google Scholar 

  97. Zahn R, Schiele R, Hauptmann KE, et al. Longer pre-hospital delays are associated with increasing mortality in patients with acute myocardial infarction treated with intravenous thrombolysis but not in patients treated with primary angioplasty. Circulation 1999; 100(Suppl I):I-358-I-359 (abstract).

    Google Scholar 

  98. Zahn R, Schneider S, Schiele R, et al. Primary angioplasty in acute myocardial infarction: is there an influence of time from onset of symptoms to start of treatment on in-hospital delay and clinical course? Eur Heart J 1999; 20 (Suppl): 400 (abstract).

    Google Scholar 

  99. Weaver WD. Relation of time to treatment on relative effects of primary coronary angioplasty vs. thrombolytic therapy. J Am Coll Cardiol 2000; 35: 376A (abstract).

    Google Scholar 

  100. Kennedy JW, Stadius ML. Combined thrombolytic and platelet glycoprotein IIb/IIIa inhibitor therapy for acute myocardial infarction: will pharmacological therapy ever equal primary angioplasty? Circulation 1999; 99: 2714–2716.

    Article  PubMed  CAS  Google Scholar 

  101. Vrachatis A, Alpert M, Nikas D, et al. Primary angioplasty re-establishes basal coronary artery flow faster than thrombolysis after acute Q-wave myocardial infarction. Circulation 1999; 100 (Suppl I): I - 358 (abstract).

    Google Scholar 

  102. Hirshfield JW Jr, Ellis SG, Faxon DP, et al. Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures: statement of the American College of Cardiology. J Am Coll Cardiol 1998; 31: 722–743.

    Article  Google Scholar 

  103. Jollis JG, Peterson ED, DeLong ER, et al. The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. N Engl J Med 1994; 331: 1625–1629.

    Article  PubMed  CAS  Google Scholar 

  104. Jollis JG, Peterson ED, Nelson CL, et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. Circulation 1997;95:2485– 2491.

    Google Scholar 

  105. Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA 1997; 277: 892–898.

    Article  PubMed  CAS  Google Scholar 

  106. Ritchie JL, Phillips KA, Luft HS. Coronary angioplasty: statewide experience in California. Circulation 1993; 88: 2735–2743.

    Article  PubMed  CAS  Google Scholar 

  107. GUSTO (IIb) Angioplasty Substudy Group. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes: a clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 3365: 1621–1628.

    Google Scholar 

  108. O’Neill WW, Griffin JJ, Stone G, et al. Operator and institutional volume do not affect the procedural outcome of primary angioplasty therapy. J Am Coll Cardiol 1996; 27 (Suppl A): 13A (abstract).

    Article  Google Scholar 

  109. Zahn R, Vogt A, Neuhaus KL, et al. Angioplasty in acute myocardial infarction in clinical practice: results in 4625 patients from the ALKK Angioplasty Registry. J Am Coll Cardiol 1997; 29 (Suppl A): 15A (abstract).

    Google Scholar 

  110. Huff ED. Volume of coronary angioplasty procedures and mortality rates. N Engl J Med 1995; 332: 1304.

    Article  PubMed  CAS  Google Scholar 

  111. Doucet M, Eisenberg MJ, Joseph L, Pilote L. The effect of hospital volume on long-term outcome after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 2000; 35: 12A (abstract).

    Google Scholar 

  112. Ho V. Evolution of the volume-outcome relation for hospitals performing coronary angioplasty. Circulation 2000; 101: 1806–1811.

    Article  PubMed  CAS  Google Scholar 

  113. Teirstein PS. Credentialing for coronary interventions: practice makes perfect. Circulation 1997; 95: 2467–2470.

    Article  PubMed  CAS  Google Scholar 

  114. Smith D, Dean J. Transferring patients for primary angioplasty. Heart 1997; 78: 323–324.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Thomas P. Wharton Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy Sinclair McNamara RN, BSN
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Duke Clinical Research Institute and Division of Cardiology, Duke University Health System, Durham, NC, USA

    James E. Tcheng MD

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wharton, T.P., McNamara, N.S. (2002). Primary Angioplasty in Community Hospitals without On-Site Cardiac Surgery. In: Tcheng, J.E. (eds) Primary Angioplasty in Acute Myocardial Infarction. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-155-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-155-8_6

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6248-8

  • Online ISBN: 978-1-59259-155-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation